CCOc1cc(-c2ccc(OC(=O)c3ccc(OC)cc3)c(OC)c2)cc(=O)c2c(C)oc(C)c12
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?